Helmy has been chairman of Pharco Pharmaceuticals since January 2024. In 2024, Techno Pharma, a Pharco subsidiary, signed an MoU with Pathfinder International to support USAID-led family planning and women’s health initiatives in Egypt. At Africa Health ExCon 2025, Pharco signed an MoU with Cleopatra Hospitals Group to expand access to critical care and cancer therapies. Helmy has 44 years of pharmaceutical sector experience, he is also a member of AmCham Egypt.